The proclamation would push back implementation of the EPA’s rule on the carcinogenic gas for two years as the Trump ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

Accropeutics’ drug hit the goals of a phase 2 psoriasis trial in China, prompting the biotech to “accelerate” the TYK2/JAK1 inhibitor’s development.

TotalEnergies plans to shut down the older of two ethylene-producing flexible steam crackers at the operator’s 338,000-b/d integrated refining and petrochemical platform in Antwerp, Belgium.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

CHICAGO — In a phase 2b study, treatment with a once-daily oral PCSK9 inhibitor added to statin therapy resulted in a more than 50% reduction in LDL cholesterol at 12 weeks in patients with ...

This study is focused on the application of a dual surface coating on poly (dimethylsiloxane) (PDMS) flow chambers, which aims to inhibit the contact activation pathway of coagulation. Polyethylene ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Sustainea, a joint venture between the Brazilian chemical maker Braskem and the Japanese trading firm Sojitz, plans to build a biobased ethylene glycol plant in Lafayette, Indiana. The plant will ...

C1 inhibitor protein is predominantly expressed in the liver, which has led to the suggestion that hereditary angioedema can be viewed as a metabolic liver disorder. 6 One group reported a case of ...